Huang X - Search Results

1

Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma.

Zhou L, Lin J, Wu G, Chen J, Huang X, Zhang S. Zhou L, et al. Among authors: huang x. Drug Des Devel Ther. 2020 Mar 30;14:1257-1262. doi: 10.2147/DDDT.S244102. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32280197 Free PMC article.

2

A retrospective study of concurrent chemoradiotherapy plus S-1 adjuvant chemotherapy on curative effect for treatment of patients with N3 stage nasopharyngeal carcinoma.

Zhang S, Zhou L, Huang X, Lin S. Zhang S, et al. Among authors: huang x. Cancer Manag Res. 2018 Jun 25;10:1705-1711. doi: 10.2147/CMAR.S165804. eCollection 2018. Cancer Manag Res. 2018. PMID: 29983590 Free PMC article.

3

Efficacy of concurrent chemoradiotherapy combined with nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma: A pilot study.

Zhang S, Huang X, Zhou L, Lin S. Zhang S, et al. Among authors: huang x. Medicine (Baltimore). 2018 Sep;97(38):e12503. doi: 10.1097/MD.0000000000012503. Medicine (Baltimore). 2018. PMID: 30235761 Free PMC article.

4

An open-label, single-arm phase II clinical study of induction chemotherapy and sequential Nimotuzumab combined with concurrent chemoradiotherapy in N3M0 stage nasopharyngeal carcinoma.

Zhang S, Huang X, Zhou L, Wu G, Lin J, Yang S, Chen J, Lin S. Zhang S, et al. Among authors: huang x. J BUON. 2018 Nov-Dec;23(6):1656-1661. J BUON. 2018. PMID: 30610791 Free article. Clinical Trial.

5

Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma.

Luo Y, Huang X, Zhan J, Zhang S. Luo Y, et al. Among authors: huang x. Int J Gen Med. 2021 Dec 1;14:9247-9260. doi: 10.2147/IJGM.S337769. eCollection 2021. Int J Gen Med. 2021. PMID: 34880664 Free PMC article.

6

Evaluation of the Clinical Efficacy of Intensity-Modulated Radiotherapy Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Extrahepatic Oligometastasis and Prognostic Factors for Patient Survival.

Luo Y, Huang X, Chen J, Zhang S. Luo Y, et al. Among authors: huang x. Int J Gen Med. 2023 Apr 12;16:1271-1278. doi: 10.2147/IJGM.S403316. eCollection 2023. Int J Gen Med. 2023. PMID: 37077764 Free PMC article.

7

Epstein-Barr virus-associated poorly differentiated nasopharyngeal adenocarcinoma: a case report and literature review.

Zhang S, Huang XP, Li HH, Chen ZT. Zhang S, et al. J Int Med Res. 2023 May;51(5):3000605231173839. doi: 10.1177/03000605231173839. J Int Med Res. 2023. PMID: 37203382 Free PMC article. Review.

8

Targeting GABARAPL1/HIF-2a axis to induce tumor cell apoptosis in nasopharyngeal carcinoma.

Huang X, Zhou L, Chen J, Zhang S. Huang X, et al. Iran J Basic Med Sci. 2024;27(2):157-164. doi: 10.22038/IJBMS.2023.72952.15863. Iran J Basic Med Sci. 2024. PMID: 38234672 Free PMC article.

9

Serum ferritin predicted prognosis in patients with nasopharyngeal carcinoma.

Chen Z, Liang Z, Chen K, Zhang S, Huang X, Wu G, Zhu X. Chen Z, et al. Among authors: huang x. Sci Rep. 2024 Feb 21;14(1):4311. doi: 10.1038/s41598-024-54627-3. Sci Rep. 2024. PMID: 38383702 Free PMC article.

10

The Prognostic Value of Serum Sialic Acid in Patients with Nasopharyngeal Carcinoma: A Propensity Score Matching Study.

Chen Z, Wu G, Lin X, Huang X, Zhang S, Chen K, Liang Z, Zhu X. Chen Z, et al. Among authors: huang x. Cancer Manag Res. 2024 Mar 20;16:215-224. doi: 10.2147/CMAR.S448238. eCollection 2024. Cancer Manag Res. 2024. PMID: 38525372 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,730 results

Search Page

Filters